Parallel evolutionary trajectories of extensively drug-resistant Klebsiella pneumoniae ST258 and ST307 pandemic clones: a systematic review
Canadian Journal of Microbiology · 01.01.2026 · 72 · 1-12
DOI: 10.1139/cjm-2025-0268 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Canadian Journal of Microbiology, erschienen am 01.01.2026. Verfasst von Sampurna Nivedita Sarkar und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences & Bioengineering, D.Y. Patil International University, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Evolution, Molecular, Klebsiella Infections, Klebsiella pneumoniae. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Extensively drug-resistant (XDR) Klebsiella pneumoniae poses a critical threat to global public health. ST258 and ST307 are two pandemic clones that have emerged through distinct evolutionary mechanisms. Understanding their parallel trajectories is essential for clinical management and therapeutic development. This systematic review examined peer-reviewed literature on K. pneumoniae ST258 and ST307 (1995–2025) from PubMed, Scopus, Google Scholar, and Web of Science. We extracted data on resistance genes, virulence factors, geographic distribution, and clinical outcomes. Inclusion criteria: studies with molecular or genomic characterization of ST258/ST307 isolates. Analysis revealed distinct evolutionary pathways. ST258 (emerged 1995, USA) showed recombination driven evolution with stable bla KPC-2/3 resistance, remaining hospital-endemic and declining after 2015. ST307 (emerged 2008, Netherlands) demonstrated plasmid-mediated adaptability with diverse carbapenemases ( bla NDM , bla OXA-48 , bla KPC ), achieving rapid global dissemination across six WHO regions by 2025. Both achieved pandemic status through different mechanisms. ST307 shows emerging hypervirulent sublineages in Europe and South America. Two distinct evolutionary strategies converge to create a unified pandemic threat. ST258’s stability contrasts with ST307’s adaptability, reflecting different fitness landscapes. Both clones exhibit limited susceptibility to current therapeutic options, with emerging resistance to last-resort agents. ST258 and ST307 represent complementary pandemic threats requiring coordinated global surveillance, antimicrobial development, and research into evolutionary dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biosciences & Bioengineering, D.Y. Patil International University, Pune, Maharashtra, India.
- Department of Biomedical Laboratory Science and Management, Vidyasagar University, Midnapore, West Bengal, India.
ORCID-Profile: Sampurna Nivedita Sarkar, Surojit Das
Zitieren
APA
Sarkar, S., & Das, S. (2026). Parallel evolutionary trajectories of extensively drug-resistant Klebsiella pneumoniae ST258 and ST307 pandemic clones: a systematic review. Canadian Journal of Microbiology, 72, 1-12. https://doi.org/10.1139/cjm-2025-0268
Vancouver
Sarkar S, Das S. Parallel evolutionary trajectories of extensively drug-resistant Klebsiella pneumoniae ST258 and ST307 pandemic clones: a systematic review. Canadian Journal of Microbiology. 2026;72:1-12. doi:10.1139/cjm-2025-0268
BibTeX
@article{Sarkar2026,
author = {Sarkar, Sampurna Nivedita and Das, Surojit},
title = {Parallel evolutionary trajectories of extensively drug-resistant Klebsiella pneumoniae ST258 and ST307 pandemic clones: a systematic review},
journal = {Canadian Journal of Microbiology},
year = {2026},
volume = {72},
pages = {1--12},
doi = {10.1139/cjm-2025-0268}
}
EUVIMED